ZoomMed Inc.: Filing of the Annual Financial Statements


MONTREAL, QUEBEC--(Marketwired - Oct. 17, 2014) - ZoomMed Inc. (TSX VENTURE:ZMD) - ZoomMed announces that it has proceed today with the filing of its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014.

The Corporation has got from the proper securities regulatory authorities a management cease trade order under the Policy Statement 12-203 Respecting cease trade orders for continuous disclosure defaults (the "Policy Statement 12-203"). As of the date of this news release, the Corporation is not subjet to any insolvency proceedings and no other important information on the Corporation's business had not already been made public. Except as disclosed in the press release, there are no material change to the information contained in the last press release regarding the present matter and no subsequent default is anticipated.

About ZoomMed

ZoomMed builds and operates "ZoomMed's communication network", a clinical information exchange platform between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations and private insurers. The cornerstone of this network is ZoomMed's "ZRx Prescriber", a technological innovative Web application that greatly simplifies the writing of a prescription for the physician. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements made in this news release that are not historical facts are "forward-looking statements" and readers are cautioned that any such statements are not guarantees of future performance, and that actual developments or results, may vary materially from those in these "forward-looking" statements.

Contact Information:

ZoomMed Inc.
Mr. Yves Marmet
President and Chief Executive Officer
(450) 678-5457, Ext 228
info@zoommed.com
www.zoommed.com